FCMI

Foresite Capital Management III Portfolio holdings

AUM $37.9M
This Quarter Return
-6.34%
1 Year Return
-6.87%
3 Year Return
+443.49%
5 Year Return
+535.97%
10 Year Return
AUM
$106M
AUM Growth
Cap. Flow
+$106M
Cap. Flow %
100%
Top 10 Hldgs %
82.65%
Holding
18
New
17
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 84.19%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
WVE icon
1
Wave Life Sciences
WVE
$1.53B
$22.5M 19.95% +1,410,689 New +$22.5M
GBT
2
DELISTED
Global Blood Therapeutics, Inc.
GBT
$14.9M 13.19% +460,000 New +$14.9M
ALDR
3
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$7.59M 6.73% +229,895 New +$7.59M
EPZM
4
DELISTED
Epizyme, Inc
EPZM
$7.4M 6.56% +461,651 New +$7.4M
LRMR icon
5
Larimar Therapeutics
LRMR
$310M
$6.92M 6.13% +1,099,700 New +$6.92M
AIMT
6
DELISTED
Aimmune Therapeutics, Inc.
AIMT
$6.55M 5.81% +355,020 New +$6.55M
RGLS
7
DELISTED
Regulus Therapeutics
RGLS
$6.27M 5.56% +718,997 New +$6.27M
AERI
8
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$5.67M 5.03% +232,757 New +$5.67M
OREX
9
DELISTED
Orexigen Therapeutics, Inc.
OREX
$5.16M 4.58% +3,000,000 New +$5.16M
XENT
10
DELISTED
Intersect ENT, Inc
XENT
$4.5M 3.99% +200,000 New +$4.5M
NDRM
11
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$4.47M 3.96% +261,945 New +$4.47M
LPCN icon
12
Lipocine
LPCN
$15.8M
$4.27M 3.78% +330,000 New +$4.27M
AKTX
13
Akari Therapeutics
AKTX
$24.8M
$3.83M 3.39% +263,921 New +$3.83M
XLRN
14
DELISTED
Acceleron Pharma Inc.
XLRN
$2.44M 2.16% +50,047 New +$2.44M
RGNX icon
15
Regenxbio
RGNX
$451M
$1.66M 1.47% +100,000 New +$1.66M
DMTX
16
DELISTED
Dimension Therapeutics, Inc
DMTX
$1.11M 0.98% +98,297 New +$1.11M
IMGN
17
DELISTED
Immunogen Inc
IMGN
$581K 0.52% +42,815 New +$581K
DYAX
18
DELISTED
DYAX CORPORATION
DYAX
0